Lack of correlation between O-serotype, bacteriophage susceptibility and genomovar status in the Burkholderia cepacia complex

FEMS Immunology and Medical Microbiology

Volumn 35, Issue 2, 2003, Pages 87-92

  Kenna, Dervla T ^a   Barcus, Victoria A ^a   Langley, Ross J ^a   Vandamme, Peter ^b   Govan, John R W ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Bacteriophage; Burkholderia cepacia complex; Cystic fibrosis; Lipopolysaccharide; Serotypes

Indexed keywords

ANTIGEN; LIPOPOLYSACCHARIDE;

ADAPTATION; ARTICLE; BACTERIOPHAGE; BACTERIUM ISOLATE; BINDING AFFINITY; BURKHOLDERIA CEPACIA; CONTROLLED STUDY; CORRELATION ANALYSIS; HOST; NONHUMAN; PRIORITY JOURNAL; SEROTYPE;

BURKHOLDERIA CEPACIA;

EID: 0037456631     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(02)00442-X     Document Type: Article

References (46)

1. Coenye T., Vandamme P., Govan J.R.W., LiPuma J.J. Taxonomy and identification of the Burkholderia cepacia complex. J. Clin. Microbiol. 39:2001;3427-3436.
2. Burkholder W.H. Sour skin, a bacterial rot of onion bulbs. Phytopathology. 40:1950;115-117.
3. Govan J.R.W., Hughes J.E., Vandamme P. Burkholderia cepacia: medical, taxonomic and ecological issues. J. Med. Microbiol. 45:1996;395-407.
4. LiPuma J.J. Burkholderia cepacia: management issues and new insights. Clin. Chest Med. 19:1998;473-486.
5. Mahenthiralingam E., Baldwin A., Vandamme P. Burkholderia cepacia complex infection in patients with cystic fibrosis. J. Med. Microbiol. 51:2002;533-538.
6. Berriatua E., Ziluaga I., Miguel-Virto C., Uribarren R., Juste R., Laevens S., Vandamme P., Govan J.R.W. Outbreak of subclinical mastitis in a flock of dairy sheep associated with Burkholderia cepacia complex infection. J. Clin. Microbiol. 39:2001;990-994.
7. Parke J., Gurian-Sherman D. Diversity of the Burkholderia cepacia complex and implications for risk assessment of biological control strains. Annu. Rev. Phytopathol. 39:2001;225-258.
8. LiPuma J.J., Spilker T., Gill L.H., Campbell P.W. III, Liu L., Mahenthiralingam E. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am. J. Respir. Crit. Care Med. 164:2001;92-96.
9. Aris R.M., Routh J.C., LiPuma J.J., Heath D.G., Gilligan P.H. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Am. J. Respir. Crit. Care. Med. 164:2001;2102-2106.
10. De Soyza A., Egan C., Ellis C.D., McDowell A., Moore J., Elborn R., De Hormaeche R., Corris P.A. The role of genomovars in Burkholderia cepacia proinflammatory activity. Thorax. 55:(Suppl.):2000;A12.
11. Rietschel E.T., Kirkae T., Schade F.U., Ulmer A.J., Holst O., Brade H., Schmidt G., Mamat U., Grimmecke H., Kusumoto S., Zahringer U. The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology. 187:1993;169-190.
12. Shaw D., Poxton I.R., Govan J.W.R. Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide. FEMS Immunol. Med. Microbiol. 11:1995;99-106.
13. Zughaier S.M., Ryley H.C., Jackson S. Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumour necrosis factor alpha from human monocytes. Infect. Immun. 67:1999;1505-1507.
14. Hughes J.E., Stewart J., Barclay G.R., Govan J.R.W. Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia. Infect. Immunol. 65:1997;4281-4287.
15. Evans E., Poxton I.R., Govan J.R.W. Lipopolysaccharide chemotypes of Burkholderia cepacia. J. Med. Microbiol. 48:1999;825-832.
16. Mahenthiralingam E., Bischof J., Byrne S.K., Radomski C., Davies J.E., Av-Gay Y., Vandamme P. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J. Clin. Microbiol. 38:2000;3165-3173.
17. Heidt A., Monteil H., Richard C. O and H serotyping of Pseudomonas cepacia. J. Clin. Microbiol. 18:1983;738-740.
18. Richard C., Monteil H., Megraud F., Chatelain R., Laurent B. Caractères phénotypiques de 100 souches de Pseudomonas cepacia; proposition d'un schéma de biovars. Ann. Biol. Clin. 39:1981;9-15.
19. Monteil H., Richard C., Heidt A. Pseudomonas cepacia: intérêt épidémiologique de la détermination des sérogroupes O des souches hospitalières. Med. Mal. Infect. 11:1981;544-547.
20. Rabkin C.S., Jarvis W.R., Anderson R.L., Govan J., Klinger J., LiPuma J., Martone W.J., Monteil H., Richard C., Shigeta S., Sosa A., Stull T., Swenson J., Woods D. Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. Rev. Infect. Dis. 11:1989;600-607.
21. Nzula S., Vandamme P., Govan J.R.W. Sensitivity of the Burkholderia cepacia complex and Pseudomonas aeruginosa to transducing bacteriophages. FEMS Immunol. Med. Microbiol. 11:2000;99-106.
22. Mahenthiralingam E., Coeyne T., Chung J.W., Speert D.P., Govan J.R.W., Taylor P., Vandamme P. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J. Clin. Microbiol. 38:2000;910-913.
23. Speert D.P., Henry D., Vandamme P., Corey M., Mahenthiralingam E. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg. Infect. Dis. 8:2002;181-187.
24. Agodi A., Mahenthiralingam E., Barchitta M., Giannono V., Sciacca A., Stefani S. Burkholderia cepacia complex in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status. J. Clin. Microbiol. 39:2001;2891-2896.
25. Bevivino A., Dalmastri C., Tabacchioni S., Chiarini L., Belli M.L., Piana S., Matezarro A., Vandamme P., Manno G. Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility. J. Clin. Microbiol. 40:2002;846-851.
26. Mahenthiralingam E., Vandamme P., Campbell M., Henry D.A., Gravelle A.M., Wong L.T.K., Davidson G.F., Wilcox P.G., Nakielna B., Speert D.P. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Clin. Infect. Dis. 33:2001;1469-1475.
27. Vandamme P., Mahenthiralingam E., Holmes B., Coenye T., Hoste B., de Vos P., Henry D., Speert D.P. Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV). J. Clin. Microbiol. 38:2000;1042-1047.
28. Vinion-Dubiel, A., Spilker, T., Dean, C.R., LiPuma, J.J. and Goldberg, J.B. (2002) Lack of correlation of serotype and genomovar in Burkholderia cepacia complex. International Burkholderia cepacia Working Group. San Antonio. Abstract p. 11, http//go.to/cepacia.
29. Cihlar R.L., Lessie T.G., Holt S.C. Characterization of bacteriophage CP1, an organic solvent sensitive phage associated with Pseudomonas cepacia. Can. J. Microbiol. 24:1978;1404-1412.
30. Matsumoto H., Itoh Y., Ohta S., Terawaki Y. A generalised transducing phage of Pseudomonas cepacia. J. Gen. Microbiol. 132:1986;2583-2586.
31. Wood M.S., Byrne A., Lessie T.G. IS406 and IS407, two gene-activating insertion sequences from Pseudomonas cepacia. Gene. 105:1991;101-105.
32. Tyler S.D., Rozee K.R., Johnson W.M. Identification of IS1356, a new insertion sequence, and its association with IS402 in epidemic strains of Burkholderia cepacia infecting cystic fibrosis patients. J. Clin. Microbiol. 34:1996;1610-1616.
33. Hubner A., Hendrickson W. A fusion promoter created by a new insertion sequence, IS1490, activates transcription of 2,4,5-trichlorophenoxyacetic acid catabolic genes in Burkholderia cepacia AC1100. J. Bacteriol. 179:1997;2717-2723.
34. Holloway B.W., Cooper G.N. Lysogenic conversion in Pseudomonas aeruginosa. J. Bacteriol. 84:1962;1324.
35. Allison G.E., Verma N.K. Serotype-converting bacteriophages and O-antigen modification in Shigella flexneri. Trends Microbiol. 8:2000;17-23.
36. Lerouge I., Vanderleyden J. O antigen structural variation: mechanisms and possible roles in animal/plant-microbe interactions. FEMS Microbiol. Rev. 26:2001;17-47.
37. Carlson R.W. Heterogeneity of Rhizobium lipopolysaccharide. J. Bacteriol. 158:1984;1012-1017.
38. Raymond C.K., Sims E.H., Kas A., Spencer D.H., Kutyavin T.V., Ivey R.G., Zhou Y., Kaul R., Clendenning J.B., Olsen M.V. Genetic variation at the O antigen biosynthetic locus in Pseudomonas aeruginosa. J. Bacteriol. 184:2002;3614-3622.
39. Parker C.T., Kloser A.W., Schnaitman C.A., Stein M.A., Gottesman S., Gibson B.W. Role of the rfaG and rfaP genes in determining the lipopolysaccharide core structure and cell surface properties of Escherichia coli K-12. J. Bacteriol. 174:1992;2525-2538.
40. Yokoto S., Hayashi T., Matsumoto H. Identification of the lipopolysaccharide core region as the receptor site for a cytotoxin-converting phage, phi CTX, of Pseudomonas aeruginosa. J. Bacteriol. 176:1994;5262-5269.
41. Schafer A., Geis A., Neve H., Teuber M. Bacteriophage receptors of Lactococcus-lactis subspecies cremoris WG2-1. FEMS Microbiol. Lett. 78:1991;69-74.
42. Woods D.E., Jeddeloh J.A., Fritz D.L., DeShazer D. Burkholderia thailandensis E125 harbors a temperate bacteriophage specific for Burkholderia mallei. J. Bacteriol. 184:2002;4003-4017.
43. de Boer A.S., Kremer K., Borgdorff M.W., de Haas P.E.W., Heersma H., van Soolingen D. Genetic heterogeneity in Mycobacterium tuberculosis isolates reflected in IS6110 restriction fragment length polymorphism patterns as low-intensity bands. J. Clin. Microbiol. 38:2000;4478-4485.
44. Naas T., Blot M., Fitch W.M., Arber W. Insertion sequence-related genetic variation in resting Escherichia coli. Genetics. 136:1994;721-730.
45. Johnson W.M., Tyler S.D., Rozee K.R. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J. Clin. Microbiol. 31:1994;924-930.
46. Pitt T.L., Kaufmann M.E., Patel P.S., Benge L.C.A., Gaskin S., Livermore D.M. Type characterization and multiple antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J. Med. Microbiol. 44:1996;203-210.